We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rtw Biotech Opportunities Ltd | LSE:RTWG | London | Ordinary Share | GG00BKTRRM22 | ORD NPV (GBP) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 105.00 | 104.00 | 106.00 | 0.00 | 08:00:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | 2.17M | -5.29M | -0.0251 | -41.83 | 221.17M |
TIDMRTW
RNS Number : 6369V
RTW Venture Fund Limited
06 April 2023
LEI: 549300Q7EXQQH6KF7Z84
6 April 2023
RTW Venture Fund Limited
Appointment of Numis as Joint Broker
RTW Venture Fund Limited (the "Company"), a London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to announce that it has appointed Numis with immediate effect as Joint Corporate Broker alongside BofA Securities, who remain Joint Corporate Broker.
For Further Information:
RTW Investments, LP +44 (0)20 7959 6361 Woody Stileman, Managing Director Krisha McCune, Director, Client Service Buchanan +44 (0)20 7466 5107 Charles Ryland Henry Wilson George Beale Numis +44 (0)20 7260 1000 Freddie Barnfield Nathan Brown Euan Brown BofA Securities +44 (0) 20 7628 1000 Edward Peel Kieran Millar Elysium Fund Management Limited +44 (0) 14 8181 0100 Joanna Duquemin Nicolle, Chief Executive Officer Sadie Morrison, Managing Director Morgan Stanley Fund Services USA LLC +1 (914) 225 8885
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more information.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
APPGIGDSBDGDGXL
(END) Dow Jones Newswires
April 06, 2023 07:00 ET (11:00 GMT)
1 Year Rtw Biotech Opportunities Chart |
1 Month Rtw Biotech Opportunities Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions